Drug Profile
Research programme: sodium channel antagonists - Unibioscreen
Alternative Names: UNBS 5200Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Unibioscreen
- Class
- Mechanism of Action Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer; Glioblastoma
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in Belgium
- 16 Jul 2016 No recent reports of development identified for preclinical development in Glioblastoma in Austria
- 16 Jul 2016 No recent reports of development identified for preclinical development in Glioblastoma in Belgium